This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marchbank, T. Articles by Playford, R. J. Search for Related Content PubMed PubMed Citation Articles by Marchbank, T. Articles by Playford, R. J.

American Journal of Pathology, Vol 148, 715-722, Copyright © 1996 by American Society for Investigative Pathology

REGULAR ARTICLES

Distribution and expression of pancreatic secretory trypsin inhibitor and its possible role in epithelial restitution

T Marchbank, R Chinery, AM Hanby, R Poulsom, G Elia and RJ Playford
Department of Medicine, University of Leicester, Royal College of Surgeons, London, United Kingdom.

Pancreatic secretory trypsin inhibitor (PSTI) is a potent serine protease inhibitor that prevents excessive digestion of the gastrointestinal mucus but may also directly affect epithelial function. We therefore examined the distribution of PSTI in the human adult and fetus using immunohistochemistry and in situ hybridization and examined its effects on cell proliferation and migration in vitro. PSTI peptide and mRNA were found in the exocrine pancreas, mucus- producing cells of the normal gastrointestinal tract, acinar component of the normal breast, and surface epithelial cells at the edge of benign gastric ulcers. Peptide, but not message, was identified in the renal proximal tubule, probably reflecting reabsorption of filtered peptide. Purified human PSTI did not affect proliferation of the human colonic cell line HT-29 but caused a threefold increase in the rate of migration in an in vitro wounding model of restitution. This effect was inhibited by co-administering a PSTI-neutralizing antibody, a transforming growth factor-beta-neutralizing antibody, or an epidermal growth factor receptor-blocking antibody. As PSTI is widely distributed in several human organ systems and stimulates cell migration in vitro, we conclude that PSTI is likely to have additional roles to that of preserving the gastrointestinal mucous layer from excessive digestion.

This article has been cited by other articles:

				T. Marchbank, A. Mahmood, A. J. Fitzgerald, J. Domin, M. Butler, R. A. Goodlad, G. Elia, H. M. Cox, D. A. van Heel, S. Ghosh, et al. Human Pancreatic Secretory Trypsin Inhibitor Stabilizes Intestinal Mucosa against Noxious Agents Am. J. Pathol., November 1, 2007; 171(5): 1462 - 1473. [Abstract] [Full Text] [PDF]

				K Kume, A Masamune, K Kikuta, and T Shimosegawa [-215G>A; IVS3+2T>C] mutation in the SPINK1 gene causes exon 3 skipping and loss of the trypsin binding site. Gut, August 1, 2006; 55(8): 1214 - 1214. [Full Text] [PDF]

				N Vergnolle CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT Gut, June 1, 2005; 54(6): 867 - 874. [Full Text] [PDF]

				K. Cederqvist, C. Haglund, P. Heikkila, T. Sorsa, T. Tervahartiala, U.-H. Stenman, and S. Andersson Pulmonary Trypsin-2 in the Development of Bronchopulmonary Dysplasia in Preterm Infants Pediatrics, September 1, 2003; 112(3): 570 - 577. [Abstract] [Full Text] [PDF]

				C. P. Diggle, S. Cruickshank, J. D. Olsburgh, S. Pellegrin, B. Smith, R. E. Banks, P. J. Selby, M. A. Knowles, J. Southgate, and P. Harnden Identification of Genes Up-Regulated in Urothelial Tumors: The 67-kd Laminin Receptor and Tumor-Associated Trypsin Inhibitor Am. J. Pathol., August 1, 2003; 163(2): 493 - 504. [Abstract] [Full Text] [PDF]

				U.-H. Stenman Tumor-associated Trypsin Inhibitor Clin. Chem., August 1, 2002; 48(8): 1206 - 1209. [Abstract] [Full Text] [PDF]